AZ to ink generic pact with Intas; Court issues ruling on viewing corporate minutes;

@FiercePharma: Pfizer, Merck make list of 'Layoff Kings'. Story | Follow @FiercePharma

> London-headquartered AstraZeneca is close to signing a licensing and supply agreement with Ahmedabad-based Intas Pharmaceuticals for generic injectables, two people familiar with the development said. News

> A New Jersey appeals court held Tuesday that shareholders have a right under state law to view corporate board and executive committee minutes, but imposed parameters to prevent "fishing expeditions" for corporate mismanagement. Story

> Thousands of Irish patients taking the anti-clotting drug warfarin may be at risk of complications if they receive an alternative brand of the drug, the State's drug safety watchdog has said. Report

> Indian pharma companies are looking at Russian drug manufacturers to explore opportunities for joint production initiatives. The effort will now be on an aggressive mode following the communiqué from the government of Russia which has rolled out a slew of incentives to encourage local production from 2015. Story

> One week after Medicis Pharmaceutical reported strong quarterly profit and sales, four top executives sold shares worth more than $12 million. Article

> The government is considering a set of proposals by global drugmakers that seeks certain changes in the country's intellectual property rights regime that can compromise Indian drugmakers ability to sell low-cost medicines. News

> Recent changes to provincial drug plans are not to blame for significant medication shortages, the Canadian generic drug industry says. Item

Biotech News

 @FierceBiotech: Biogen pays $80M to buddy up on PhIII ALS program. Story  | Follow @FierceBiotech

 @JohnCFierce: This is way late, but if I was in alzheimer's R&D, I'd be scared right down to my boots. talk about flying blind. | Follow @JohnCFierce

> Takeda maps out obesity strategy as it confronts blockbuster loss. Item

> Benlysta, BMS melanoma drug win accelerated FDA review. Article

> Report: Equity group orchestrates $600M INC buyout. News

Vaccines News

> Selecta gets a new CEO, $3M for nicotine vax program. Report

> CSL predicts profit drop on lower vax sales. Story

> MRSA vax breakthrough reported by UChicago team. Item

> Critics deride WHO's ties to vaccine industry. Report

Manufacturing News

> Buffett smells opportunity in Tylenol mis-manufacturing. Story

> Abbott warning cites lack of worker qualifications. News

> Teva workers were WARNed of layoffs last May. Item

> McKesson eyes automation for distribution center. Report

And Finally... Drinking wine in moderate amounts may reduce the risk of decline in thinking skills in some people and may even protect against dementia, a new study shows. Report